Thank you, Craig and good afternoon, everyone. We continue to execute our strategy, achieving significant growth in total investment income as a result of our growing portfolio and our capital deployment into debt instruments. This past quarter, our portfolio optimization efforts did include selective asset sales which generated capital we used to enhance our balance sheet which will position us rather favorably for future growth opportunities. I'm very excited to highlight and remind you all that last month, we announced the acquisition of one of our portfolio investments, SciAps which is one of our larger legacy equity and debt holdings by U.K.-based Spectris plc. The transaction which is expected to be completed later this year is valued at up to $260 million. This does include a deferred component of $60 million earnout. Rand holds approximately 6% of SciAps' equity with our total investment costing $5.2 million and does include a secured note from 2021. As of June 30, we have valued this total investment into SciAps at $10.8 million. We are carefully evaluating the best options for the anticipated capital infusion from this acquisition. We recognize that we need to strategically redeploy these funds to the extent possible through new investments as well as reinvesting in existing portfolio companies which show high potential. This approach aims to drive further value for our shareholders and may also include additional returns in the form of dividends down the road. The achievement of our strategic objectives over the last few years has translated into tangible benefits for our shareholders. This is highlighted on Slide 4. Year-to-date, we have declared total dividends of $0.83 per share. This includes a cash dividend of $0.29 per share rather for the second quarter. More recently, on July 31, we announced that our third quarter 2024 dividend will continue to be held at $0.29 per share. At quarter end, after deploying capital and distributing $748,000 in cash dividends to shareholders, we maintained total available liquidity of over $11 million. This liquidity includes our line of credit availability, cash on hand and our remaining highly liquid publicly traded BDC securities. If you turn to Slide 5, you will see our portfolio mix between debt and equity and the changes during the recent quarter. Our portfolio had a fair value of $87.1 million across 26 businesses. This is up 13% from year-end 2023 and 5% sequentially. The increases reflect investments in valuation adjustments in multiple companies, including SciAps, partially offset by stock sales and portfolio loan repayments. Our portfolio is comprised of approximately 66% debt investments with an annualized weighted average yield of 13.8%, including PIK interest. The remaining mix includes 32% equity investments in private companies and thus primarily consist of SciAps and Tilson as well as 2% in publicly traded BDC investments. During the quarter, we completed a follow-on equity investment which is highlighted on Slide 6. We invested $108,000 in food service supply or FSS, who is a commercial kitchen supply and services company based in Utah. Following this investment, our total debt and equity holdings in FSS reflect a fair value of $7.5 million at quarter end. The bottom half of the slide highlights notable exits and repayments for the quarter. We received $3.3 million in total proceeds from liquidating our shareholdings in 3 BDC investments. This resulted in realized gains of $598,000 from Carlyle, $485,000 from PennantPark and $177,000 from Ares. Additionally, we recognized a realized gain of $397,000 from a partial asset sale of a Tilson affiliated entity called SQF. We also received $740,000 principal loan repayments from our PressurePro debt investments. Lastly, we exited our equity investment in KNOA which had been previously valued at 0. Slide 7, if you kindly turn to that, visually illustrates the diversity within our portfolio and the changes in our industry allocation over the second quarter. Recent investments and adjustments in fair value led to changes in our industry composition. Manufacturing increased from 20% to 25% of our portfolio, while the BDC stocks following their sales decreased from 5% to 2%. We place a high value on the diversity of our industry mix. The broad spectrum of sectors across the portfolio reflects our strategic approach, ensuring resilience in a difficult economy and mitigating risk in our investment efforts. Slide 8 lists our top 5 portfolio companies at quarter end. And consistent with my prior comments regarding our larger legacy equity holdings, Tilson remains our largest fair value investment at $12.3 million, marking a 17% increase from the prior quarter and representing 14% of our total portfolio. SciAps' moved up to the second position with its value more than doubling to $10.8 million following the announced definitive purchase agreement. Overall, the top 5 companies represent 50% of our total portfolio at quarter end. With that, I'll turn it over to Margaret to review our financials in greater depth.